Name: ABSA’s 1st Biosecurity Symposium
Start: 2021-04-20T00:00:00-05:00
End: 2021-04-23T23:59:59-05:00
Location: Renaissance Depot Hotel

Large Clinical Trial in Africa Tests Treatments for Mild and Moderate COVID-19 Cases

Oxford-AstraZeneca COVID-19 Vaccine: Cheaper and Doesn’t Require Supercold Storage Quagmire
Altimmune Poised to Begin Phase 1 Clinical Trial of Single-Dose Intranasal COVID-19 Vaccine
COVID-19 Vaccines Were Developed in Record Time – But are These Game-Changers Safe?

New Study Casts Doubt on Benefit of Tocilizumab for Worsening Cases of COVID-19

by Global Biodefense Staff October 24, 2020, 3:35 pm
Hydroxychloroquine as Pre-Exposure Prophylaxis: Randomized Clinical Trial Shows No Benefit

by Global Biodefense Staff October 23, 2020, 3:07 pm
BARDA Awards Medical Countermeasures Clinical Studies Network Contracts

by Global Biodefense Staff October 20, 2020, 1:40 pm
Autoimmune-Like Antibody Response Linked with Severe COVID-19

by Matthew Woodruff October 10, 2020, 8:30 am
Pipeline COVID-19 Vaccines Not Affected by ‘G-Strain’ Mutation

by Global Biodefense Staff October 8, 2020, 7:01 am
NIH Expands COVID-19 Convalescent Plasma Clinical Trials

by Global Biodefense Staff September 22, 2020, 10:16 am
WHO Meta-Analysis: Corticosteroids Save Lives of Critically Ill COVID-19 Patients

by Andrew McLachlan, University of Sydney September 3, 2020, 9:32 am
Lessons From Hydroxychloroquine: Improving FDA’s Authorization and Approval Process

by Global Biodefense Staff August 31, 2020, 3:20 pm
Urgent Phase I/II Clinical Trial Funding to Repurpose Existing Therapeutics to Treat COVID-19

by Global Biodefense Staff August 6, 2020, 1:18 pm
NIAID-Led Study of COVID-19 mRNA Vaccine Supports Advance to Phase 3 Human Trials

by Global Biodefense Staff July 28, 2020, 3:47 pm
Newsletter

Global Biodefense News

First Name

Last Name

Organization Type

Email address:

Don't worry, we don't spam
Moderna’s COVID-19 Vaccine Generally Well Tolerated in Ongoing Phase 1 Trial

by Global Biodefense Staff July 14, 2020, 6:06 am
Thailand Begins Coronavirus Vaccine Trials on Monkeys

by Global Biodefense Staff May 23, 2020, 4:10 pm
Canadian Team First in World to Treat COVID-19 With Specialized Dialysis

by Global Biodefense Staff May 23, 2020, 7:00 am
First Human Trial of COVID-19 Vaccine Finds it is Safe and Induces Rapid Immune Response

by Global Biodefense Staff May 22, 2020, 2:22 pm

Congratulations. You've reached the end of the internet.

Clinical Trials

Large Clinical Trial in Africa Tests Treatments for Mild and Moderate COVID-19 Cases

Oxford-AstraZeneca COVID-19 Vaccine: Cheaper and Doesn’t Require Supercold Storage Quagmire

Altimmune Poised to Begin Phase 1 Clinical Trial of Single-Dose Intranasal COVID-19 Vaccine

COVID-19 Vaccines Were Developed in Record Time – But are These Game-Changers Safe?

New Study Casts Doubt on Benefit of Tocilizumab for Worsening Cases of COVID-19

Hydroxychloroquine as Pre-Exposure Prophylaxis: Randomized Clinical Trial Shows No Benefit

BARDA Awards Medical Countermeasures Clinical Studies Network Contracts

Autoimmune-Like Antibody Response Linked with Severe COVID-19

Pipeline COVID-19 Vaccines Not Affected by ‘G-Strain’ Mutation

NIH Expands COVID-19 Convalescent Plasma Clinical Trials

WHO Meta-Analysis: Corticosteroids Save Lives of Critically Ill COVID-19 Patients

Lessons From Hydroxychloroquine: Improving FDA’s Authorization and Approval Process

Urgent Phase I/II Clinical Trial Funding to Repurpose Existing Therapeutics to Treat COVID-19

NIAID-Led Study of COVID-19 mRNA Vaccine Supports Advance to Phase 3 Human Trials

Moderna’s COVID-19 Vaccine Generally Well Tolerated in Ongoing Phase 1 Trial

Thailand Begins Coronavirus Vaccine Trials on Monkeys

Canadian Team First in World to Treat COVID-19 With Specialized Dialysis

First Human Trial of COVID-19 Vaccine Finds it is Safe and Induces Rapid Immune Response

Biodefense Headlines – 21 January 2021

First Cases of B.1.1.7 Variant COVID-19 Detected in Washington State

The Response Measures Database: Central Archive of COVID-19 Interventions

EU Initiative on Health Security Work Programme 2021

Rapid Identification of Ricin in Serum Samples Using LC–MS/MS

Dr. Fauci Makes First Appearance at Biden White House Press Briefing – Transcript

ASM Expresses Support for the Global Health Security Act of 2021

How and When Will Lower-Income Countries Gain Access to COVID-19 Vaccines?

OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

Emerging Infections Network – Managing Travelers Who Acquire Disease Abroad

Upcoming Events

Application Deadline: Expanding Existing Research Grants, CRADAs for Novel Coronavirus Response

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 2

Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 3

ABSA’s 1st Biosecurity Symposium

Latest stories

Latest Articles